TELA Bio Inc
NASDAQ:TELA

Watchlist Manager
TELA Bio Inc Logo
TELA Bio Inc
NASDAQ:TELA
Watchlist
Price: 1.01 USD -5.61% Market Closed
Market Cap: 44.2m USD

Wall Street
Price Targets

TELA Price Targets Summary
TELA Bio Inc

Wall Street analysts forecast TELA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TELA is 3.52 USD with a low forecast of 1.26 USD and a high forecast of 5.25 USD.

Lowest
Price Target
1.26 USD
25% Upside
Average
Price Target
3.52 USD
248% Upside
Highest
Price Target
5.25 USD
420% Upside
TELA Bio Inc Competitors:
Price Targets
ALGN
Align Technology Inc
9% Upside
6929
OrbusNeich Medical Group Holdings Ltd
71% Upside
7979
Shofu Inc
39% Upside
SMTI
Sanara Medtech Inc
81% Upside
MMSI
Merit Medical Systems Inc
31% Upside
603658
Autobio Diagnostics Co Ltd
20% Upside
XTNT
Xtant Medical Holdings Inc
124% Upside

Revenue
Forecast

Revenue Estimate
TELA Bio Inc

For the last 6 years the compound annual growth rate for TELA Bio Inc's revenue is 43%. The projected CAGR for the next 4 years is 17%.

43%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
TELA Bio Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
TELA Bio Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-66%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TELA's stock price target?
Price Target
3.52 USD

According to Wall Street analysts, the average 1-year price target for TELA is 3.52 USD with a low forecast of 1.26 USD and a high forecast of 5.25 USD.

What is TELA Bio Inc's Revenue forecast?
Projected CAGR
17%

For the last 6 years the compound annual growth rate for TELA Bio Inc's revenue is 43%. The projected CAGR for the next 4 years is 17%.

Back to Top